Lemaitre vascular inc (LMAT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net income

3,174

4,613

5,184

4,624

3,513

6,025

4,314

8,751

3,853

4,284

5,042

4,632

3,219

2,597

3,229

2,598

2,166

2,530

2,092

1,767

1,369

1,916

934

1,272

-207

746

721

889

846

698

663

824

386

346

1,214

519

64

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

1,538

1,441

1,345

1,346

1,284

1,216

1,006

1,066

1,036

1,089

1,004

983

979

933

846

931

881

897

825

840

832

912

802

789

831

819

723

641

610

601

528

557

548

571

516

489

461

Stock-based compensation

779

547

655

694

746

555

537

636

621

411

886

472

487

485

533

332

330

336

479

281

328

320

439

265

278

286

412

278

277

277

406

267

263

250

317

267

263

Fair value adjustment to contingent consideration obligations

64

48

44

35

44

-5

-66

12

30

-

-

-

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

83

Provision for doubtful accounts

71

99

70

98

121

55

63

73

73

78

48

56

48

53

4

-4

52

26

100

4

52

23

7

-7

31

22

14

-68

3

13

51

78

11

-42

-34

29

103

Provision for inventory write-downs

196

239

106

164

238

373

128

69

101

124

88

47

137

82

81

163

36

0

152

171

139

159

101

332

75

64

-16

328

103

-84

248

238

461

239

208

318

246

Provision (benefit) for deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-

-

-

-

Excess tax benefits from stock-based compensation awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

0

0

28

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

0

0

-4

-

-

-

-

-

-

-

-

-

-

-

-

Non cash restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

-1

-15

-709

Foreign currency transaction loss

-208

119

-125

9

54

-133

-30

-102

6

-5

14

-31

51

-60

-4

9

-4

30

-143

32

-19

-58

21

-18

-5

-32

19

-49

-53

-83

-10

-56

-220

-22

-39

17

200

Changes in operating assets and liabilities:
Accounts receivable

368

1,569

-330

92

-30

2,835

-2,104

1,123

-571

1,457

-1,017

209

858

854

-708

-49

825

801

-771

193

1,656

460

-619

881

-68

1,310

-760

251

446

539

-337

351

87

-248

34

-380

768

Inventory and other deferred costs

1,861

1,759

4,288

2,918

2,370

1,201

1,755

498

808

22

563

-335

1,102

-82

480

-656

392

-641

384

-746

395

223

348

1,143

997

225

622

702

619

647

1,183

1,158

737

1,062

376

-1,231

791

Prepaid expenses and other assets

-659

205

1,164

-976

261

-1,346

1,790

334

-360

-1,115

647

740

16

-1,918

656

561

-827

1,244

239

387

165

-956

490

-24

-63

-19

469

-262

48

-240

361

-398

-26

-277

430

-370

112

Accounts payable and other liabilities

-3,271

1,435

2,063

-584

-3,510

4,659

-263

1,998

-2,080

737

1,337

-160

-390

-1,302

2,081

939

-1,821

2,403

632

705

-1,123

-782

944

564

-1,812

588

874

524

-1,125

-237

1,215

1,088

-709

-2,298

1,689

-89

-2,472

Net cash provided by (used in) operating activities

1,189

5,594

4,470

4,334

-219

6,571

4,308

4,876

3,751

6,770

8,198

5,424

2,476

4,194

6,350

5,094

1,258

3,925

4,211

3,902

-600

2,682

2,896

1,623

-1,689

1,356

2,391

1,987

-346

427

1,864

2,045

386

-303

2,375

3,512

-2,414

Purchases of property and equipment and other assets

863

1,400

710

849

802

1,290

534

803

427

1,637

2,336

753

1,691

1,011

566

544

720

715

765

470

323

400

225

116

433

295

380

1,382

676

421

204

313

271

617

650

239

515

Purchases of short-term marketable securities

2,103

4,321

5,203

2,221

10,954

3,671

5,191

10,663

94

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of short-term marketable securities

3,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments related to acquisitions

59

-

-

-

-

-

-

-

-

-

-

-

-

12,000

0

-14

2,382

139

158

1,130

138

982

5,384

0

193

0

3,180

0

111

-

-

-

-

510

0

370

271

Proceeds from divestitures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250

115

131

4

3

1,303

102

6

Purchase of intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

2

-6

13

23

21

112

8

6

42

23

45

-

-

-

-

Purchase of technology and licenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

7

19

Net cash used in investing activities

-25

-3,546

-5,728

-3,070

-11,756

1,257

-3,725

-4,066

-521

-24,178

-2,336

-753

-1,691

-13,013

-566

-530

-3,102

-865

-569

-1,585

-461

-1,388

-5,611

-110

-639

-318

-3,581

-1,494

-795

-4,531

-150

-205

-312

-1,141

632

-514

-799

Financing activities
Payments of deferred acquisition consideration

-

2,000

0

26

33

28

29

1,107

35

36

39

128

260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

233

1,718

2,130

551

457

160

2,071

446

292

30

3,169

1,482

819

58

714

529

141

1,118

2,660

733

325

0

152

10,586

96

520

508

21

170

-

-

-

-

5

11

37

16

Purchase of treasury stock

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

260

0

6

0

204

6

1

39

231

13

90

36

875

508

602

754

937

146

376

Common stock cash dividend paid

1,917

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

725

715

705

700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

0

0

28

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-1,741

-2,220

16

-2,842

424

-1,303

0

-3,370

257

-1,066

1,298

-711

559

-1,042

-507

-1,169

141

847

585

28

-381

-790

-2,158

9,487

123

48

-183

-906

80

-61

-1,255

-1,239

-602

-1,476

-1,236

-728

-360

Effect of exchange rate changes on cash and cash equivalents

-265

239

-303

76

-1

-311

-117

-583

198

56

234

350

178

-501

58

-21

193

-85

-28

60

-225

-166

-285

8

-2

-1

89

21

-85

-26

18

-61

18

-35

-89

32

62

Net increase (decrease) in cash and cash equivalents

-842

67

-1,545

-1,502

-11,552

6,214

466

-3,143

3,685

-18,418

7,394

4,310

1,522

-10,362

5,335

3,374

-1,510

3,822

4,199

2,405

-1,667

338

-5,158

11,008

-2,207

1,085

-1,284

-392

-1,146

-4,191

477

540

-510

-2,955

1,682

2,302

-3,511

Supplemental disclosures of cash flow information (see Note 12)